Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we focus on Diagnos (ADK.V) which leverages proprietary AI technology and retinal scanning to revolutionize diagnosis methodology for such conditions as diabetes.

Enjoy!

 

Written By:

Gaalen Engen

More By This Author
Tags:
Artificial Intelligence
Featured Content
Health Science
Roundtable
Technology
Video
ADK.V
artificial intelligence/machine learning
best Canadian tech company
Diagnos
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments